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   Ten patients with Stage 1 non－seminomatous・ germ cell testicUlar tumorS． underwent orchiectomy
and combination chemotherapy with bleomycin， vinedstine and rnethotrexate with CF rescue （BOM）
as an induction therapy followed by cyclophosphamide， v’incristine and methotrexate as a maintenance
therapy （COM）． ’The results were as follows：’
1．，．βQM：1騨ゆ◇わ¢1サ舞φμ呂．ゆrth・； t；・．・V・・｝9Pt f・・St49・ln・n－semin・血・t・u串9・・m ccl正t・・ti・ul・・
  tumor Patients． Al・1 10 patients are alive’arid disease－free for a period’from 1 year and 6 months
  to 5 years’and 3 months （mean： 3 years and 9 months）．
2． The chemotherapy should be continued at least for a year，’si’nce reiaPse occurred in 2 of 4 patients
  Who received only inductiop therapy．’ ’However’， they complet61y responded to other chemotherapy
  regimens （BVP and BOAM）’．
3． BOM and COM therapy were scarce｝y toxic and no serious side effe¢ts were reeognized．
4． From the above results， it was considered that combination chemotherapy （BOM and COM） can
  be an alternative treatment to the conventional retroperitoneal node・dissectioh and radiation
  therapy for Stage 1 nen－seminomatous germ cell tumors．
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らびに利尿剤（frusemide 40 mg／ H）と重曹（69／日）の
経口投与によるアルカリ化7）を3日間併用した．この
Tablc 1． Patient characteristics and clinical courses






















































M： methotrexate， P： cis－diarmiinedichloroplatinum， C； cyclo－
phosphcmide，
t： elevation of serum AF’P． ＃： bone metastasis．
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MTX’ 200－300mg／sq．m     with CF rescue
      t
Day 1，2，3，一一一7 8
，e： 4－6 hour infusion， 20 minutes after
  VCR 工V Qne push．
Table 3．CF （Folinic acid） rescue





   q 6－8 hours
















































300皿g／sq。m  工V one push
lmg／sq．m IV one push
200－300mg／sq．m
2－4 hour infusion with CFrescue
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        Fig． 3a Fig 3bFlg 3a（Dec l 978），3b（Mar 1982）． Intravenous pyelogram showsユmprovement of thc
    left hydronephrosis and ureteral shift at the level of P－U Junction iollewmg the che－
    motherapy of 2－year duration．
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Fig 4 Biopsy from the left femur shows me－
    tastatic embryonal carcinoma













泌尿紀要 29巻 2号 1983年
遅tage 1 non－seminomatous testicular tumors： 2－3 year













Table 7．Stage 1 non－seminomatous testicular tumors： 2－3 year
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